Valuation
- Market cap
- 0
- Revenue TTM
- $80,380,000
- Net income TTM
- $-10,590,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -13.17%
- Debt to equity
- 0.00
Trading
- Volume
- 4,000
- Avg volume
- 20,322
- Day's range
- $0.00 – $0.00
- Shares out
- —
- Stochastic %K
- 100%
- Beta
- 0.38
- Analysts
- —
- Price target
- —
Company profile
Wuhan General Group (China), Inc., a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Reno, Nevada.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 782 413 5457
- Website
- https://wuhn.org
- Address
- 401 Ryland St. Ste 200-A, Reno, United States
Latest news
No headlines yet.
